Shanghai Junshi Biosciences soars on Hong Kong debut


HONG KONG: Chinese biotech startup Shanghai Junshi Biosciences Co Ltd soared more than 22% in its Hong Kong debut yesterday after raising US$394mil in its initial public offering (IPO), a rare strong showing by a biotech company in the Asian financial hub.

Shares of Junshi Biosciences opened at HK$23.50 (US$3) and closed at HK$23.7, about 22% above the IPO price of HK$19.38.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Junshi , IPO , Hong Kong

   

Next In Business News

Powering on data centres
Medical insurance premiums on the rise
Blackstone, KKR mortgage REITs stung by office debt challenges
Making scents of success
Tesla’s plan for affordable cars takes page from Detroit rivals
Sapura Energy takes a step to turn the tide
Are there too many GPs and is the healthcare system overwhelmed?
Kelington to reap the benefits of a diversified business strategy
Investors brace for 5% Treasury yields
Singapore’s growth trajectory remains intact

Others Also Read